Table 2.
Functional and anatomical outcomes in the MHD ≤400 mm group
| Groups | ||||
|---|---|---|---|---|
| Hole-Door (N = 8) | Foveal Flap (N = 8) | Negative (N = 9) | P | |
| Preoperative BCVA | 1.71 ± 1.53 | 0.90 ± 0.57 | 0.77 ± 0.28 | 0.11 |
| Preoperative MHD, μm | 285.75 ± 110.94 | 252.63 ± 72.19 | 289.56 ± 69.41 | 0.636 |
| Macular hole closure | 8 (100%) | 8 (100%) | 9 (100%) | / |
| ELM restoration | 8 (100%) | 8 (100%) | 9 (100%) | / |
| EZ restoration | 5 (62.5%) | 4 (50%) | 7 (77.8%) | 0.516 |
| Postoperative BCVA | 0.16 ± 0.14 | 0.23 ± 0.18 | 0.30 ± 0.12 | 0.179 |
MHD Minimum hole diameter, ELM External limiting membrane, EZ Ellipsoid zone, BCVA Best corrected visual acuity; *, for preoperative BCVA, preoperative MHD, and postoperative BCVA, P-values were determined by ANOVA. For EZ restoration, P-value determined by Chi-squared test